Director of Compliance
|
|
|
- Deirdre James
- 7 years ago
- Views:
Transcription
1 TITLE COMPANY VP & Assoc General Counsel Lundbeck USA Director of Compliance Merck VP & CCO Sanofi Sr Corp Counsel Sr Mgr Global Training CCO VP Corp & Legal Affairs Par Pharmaceutical Dir Compliance Daiichi Sankyo Sr Dir Contracts & Compliance Chiesi USA VP CCO Aegerion Pharmaceuticals VP Regulatory Affairs Compliance & Quality J Knipper & Co Assistant Deputy Chief Litigation US Department of Justice Health Care Compliance Officer Boston Office Leader Polaris VP Global Chief Regulatory Counsel Hospira
2 VP MedPro Systems Sr VP Legal Affairs General Counsel & Secretary AMAG Pharmaceuticals Sr Mgr US Testing Ops Account Exec MedPro Systems Sr Analyst Oversight & Monitoring President Potomac River s Managing Dir Navigant Health Care Compliance Officer VP Chief Corporate Compliance Officer Sandoz Vascular Surgeon Methodist Surgical Hospital Dir Compliance Merck NA Compliance Specialist Sanofi Compliance Data Analyst Vertex Pharmaceuticals Due Diligence Program Mgr Takeda Pharmaceuticals President Salient Mgr Compliance Monitoring & Investigations Shire Pharmaceuticals Managing Dir Berkeley Research Group LLC Exec VP Corp Compliance Endo Health Solutions
3 Sr Mgr Assurance Services Analyst Polaris Deputy Assoc Commissioner US Food & Drug Administration ORA Sr Dir Compliance Daiichi Sankyo Managing Dir & Practice Leader Huron Life Sciences Healthcare Compliance Officer Arnold & Porter Llp VP & Chief Ombudsman Assoc VP Compliance Ferring Pharmaceuticals Sr Consultant Polaris VP & CCO Vertex Attorney Porzio Life Sciences LLC Sr Legal Counsel & Head Compliance Keryx Biopharmaceuticals Sr IT Mgr Dir Labeling Promotion & Advertising Upsher Smith Laboratories Healthcare Compliance Officer International Mgr Assoc Dir Compliance & Ethics Sunovion Pharmaceuticals
4 Dir Commercial Compliance Takeda Pharmaceuticals Principal Advisory KPMG Sr Dir Global Contracting & Bus Practices The Medicines Company VP Assist General Counsel Exec VP NXLevel Solutions VP Sales MediSpend Counsel Ikaria Sr Corp Counsel Washington Editor Pharmaceutical Executive Sr Analyst Oversight & Monitoring VP & Chief Privacy Officer Porzio Life Sciences LLC Sr Mgr Sr Dir Government Contract Compliance Attorney OMelveny & Myers LLP Mgr Lead Analyst Sr Mgr Polaris Exec Dir Legal CCO Leo Pharma
5 Chief Knowledge Officer & General Counsel MediSpend MDM Bus Analyst Pilch Consulting Group LLC Sr Mgr Assoc Dir Audit & Monitoring Sandoz King & Spalding LLP Assoc Dir Compliance Counsel Par Pharmaceutical Dir Corporate Compliance Merz North America King & Spalding LLP CCO Pharmacyclics Attorney Paul Hastings Compliance Specialist inventiv Health Assist General Counsel Owner Operator Pilch Consulting Group LLC Sr Corp Counsel CCO Ikaria Sr Dir Compliance & Ethics Sunovion Pharmaceuticals Dir Compliance Investigations Daiichi Sankyo
6 Sr Dir Advocacy & Prof Relations Healthcare Compliance Officer VP CCO Medac Pharma Sr Dir Compliance Daiichi Sankyo Sr Corp Counsel Audit & Assurance Dir R&D GlaxoSmithKline Dir Security Ops Sandoz Regulatory Analyst Porzio Life Sciences LLC Sr Corp Counsel MDM Technical Leah Pilch Consulting Group LLC CIO Health & Wellness s Medical Science Liaison Sigma Tau Pharmaceuticals CCO DARA Biosciences Compliance Counsel Bayer Corporation Regulatory Counsel Lead Mgr Healthcare Compliance Officer Head Sales Huron Life Sciences
7 Dir Compliance Daiichi Sankyo Sr Dir IT Global Finance Bus Dev Dir Business Enterprise Mapping LLC Dir Healthcare Compliance & Ethics Ferring Pharmaceuticals US Attorney US Attorneys Office District MA Exec VP & Chief Strategy Officer Porzio Life Sciences LLC Finance Dir Pfizer Head Privacy Shire President COO Otsuka America Pharmaceutical Sr Mgr Regulatory Affairs & Compliance Grunenthal USA VP & Assistant General Counsel Lead Health Care Compliance Analyst Sr Dir FTI Consulting Consultant LRN Lead Analyst Deputy Commissioner Global Reg Ops & Policy US Food & Drug Administration Assoc Dir Corp Compliance & Ethics Dr Reddys Labs Corporate Compliance Director Sanofi US
8 Sr Account Mgr NXLevel Solutions Sr Corp Paralegal AMAG Pharmaceuticals VP Office General Counsel Kadmon East Coast Sales Mgr Pharmaceutical Executive Ops Mgr US Sales & Marketing Alcon Lead Training Analyst Mgr Compliance & Ethics Compliance Implementation Services CIS Consultant Berkeley Research Group KPMG LLP Dir Compliance Training Otsuka Healthcare Compliance Officer Dir Compliance Officer Merck & Co Principal Assurance Services US Attorney US Attorneys Office Eastern District PA Attorney OMelveny & Myers LLP VP Merck & Co Audit Mgr GlaxoSmithKline Dir Clinical Research Novartis Pharmaceuticals
9 GCCO International Mgr Commercial Ethics & Compliance Takeda Pharmaceuticals Dir Compliance Shionogi Sr Corp Counsel Counselor at Law Porzio Bromberg & Newman PC Sr Dir Health Care Compliance Sr Dir Global MedImmune Dir Exec Dir Deputy Compliance Officer Novartis Pharmaceuticals President BRG Sr Mgr Compliance Pharmacyclics Asst General Counsel Sr Legal & Compliance Counsel Theravance Biopharma US King & Spalding Medical Science Liaison Sigma Tau Pharmaceuticals Dir US Ethics & Compliance Novartis Pharmaceuticals Engagement Exec LRN
10 Asst Dir Corporate Compliance Astellas US Compliance Bus Architect Pilch Consulting Group LLC Marketing Dir Meetings & Events International Lead Health Care Compliance Analyst Managing Dir Huron Consulting Group Dir Healthcare Compliance Mallinckrodt Loeb & Loeb LLP Assoc Dir Navigant Managing Dir BRG Sr VP & Assoc General Counsel President Center for Communication Compliance Sr Dir Managing Consultant BRG Sr Corp Counsel Sr Analyst Exec Dir Merck & Co Sr Compliance Analyst AbbVie Sr Compliance Mgr Seattle Genetics
11 Dir Navigant VP Porzio Life Sciences LLC Arnold & Porter LLP Mgr Sample Compliance Takeda Pharmaceuticals USA Mgr Health Care Compliance Officer Mgr Potomac River s Simpson Thacher & Bartlett LLP Sr Corporate Counsel Novo Nordisk Legal & Regulatory Specialist Crealta Pharmaceuticals LLC Managing Dir FTI Consulting CCO BTG International EVP Bus & Legal Affairs Medi Promotions Assist Dir Global Corp Compliance Astellas US Attorney at Law Loeb & Loeb LLP US Attorney US Attorneys Office Eastern District of TN VP Compliance Ops Parexel International Corp Healthcare Compliance Officer
12 SVP Gen Counsel & Secretary CCO Amarin Pharma Arnold & Porter Assoc Dir Compliance Ironwood Pharmaceuticals Dir Polaris SVP & CCO Auxilium Assoc VP NA Compliance Genzyme a Sanofi Company Mgr IT Global Finance Sr Corp Counsel Mgr Commercial Ethics Compliance Takeda Dir Compliance Ops AbbVie Exec Dir Seton Hall Law School Chief Compliance Officer Ironwood Pharmaceuticals Regulatory Compliance Lead Mgr Director Project Management Boehringer Ingelheim Compliance Mgr & Privacy Officer Merz North America Mgr IT Global Finance
13 Assoc Mgr Compliance Training Novo Nordisk Exec Dir Expert Engagement Merck Life Sciences Exec Navigant Deputy Compliance Officer Endo Health Solutions US Attorney US Attorneys Office Western Dist VA VP Ethics & Compliance Officer AbbVie Training Mgr JJHCC&P Account Exec MedPro Systems CCO ProStrakan Medical Science Liaison Sigma Tau Pharmaceuticals Sr Dir Enterprise Risk Management Medicines Co President CEO Meetings & Events International VP & Assist General Counsel US Attorney US Attorneys Office for the District of KS Health Care Compliance Officer Corp Counsel Dir Corporate Compliance Vertex Pharmaceuticals
14 Compliance Mgr Bayer Corporation Dir Health Care Compliance Assoc Dir Compliance Monitoring & Auditing Novo Nordisk Exec VP General Counsel Kadmon Corporation Mgr Health Care Compliance Head US Ethics & Compliance Novartis Pharmaceuticals Corp Professor of Law Seton Hall Law School Principal Ernst & Young Sr Mgr Bayer Corporation Attorney Paul Hastings LLP Health Care Compliance Officer Assoc Mgr Compliance Training Novo Nordisk Lead Health Care Compliance Analyst Managing Dir Huron Consulting Group Head External Interface Office AstraZeneca Sr Consultant Navigant Litigation Department Paul Hastings LLP Corporate Counsel Bayer Corporation
15 Sr Compliance Specialist Vertex Pharmaceuticals Consultant Polaris Sr Dir FTI Consulting Chief Learning Officer Amneal Pharmaceuticals Health Care Compliance Officer Assoc Dir ex-us Regions & Compliance Audit Lead Merck Dir Strategic Bus Improvement Janssen Pharmaceutical CEO Millennium Sales Support Analyst MedPro Systems VP Compliance NA Astrazeneca Lead Analyst Compliance Bus Boehringer Ingelheim VP Distribution Licensing Services Porzio Life Sciences LLC Consultant Polaris Health Care Compliance Officer Dir Navigant Legal Counsel Emergent BioSolutions Commercial Compliance Monitoring & Analytics Mgr Takeda Pharmaceuticals
16 Sr Mgr Testing Ops Sr Compliance Analyst Otsuka Healthcare Compliance Officer Chief Health Care & Government Fraud Unit United States Attorneys Office New Jersey Sr Co-Founder Polaris Sr Technology Analyst VP & Chief Compliance Officer & Corp Counsel Lundbeck Principal Ernst & Young Former Head Corp Compliance Dept Acorda Therapeutics Dir Navigant Mgr Life Sciences Advisory Services Huron Life Sciences Mgr Assurance Services Health Care Compliance Exec Dir Commercial Compliance Boehringer Ingelheim Attorney Paul Hastings SVP Chief Risk Officer Medicines Co Sr Corporate Counsel
17 Mgr Polaris Sr Dir Health Care Quality US Compliance & Privacy Officer Actelion Pharmaceuticals Principal Managing Dir Huron Life Sciences Mgr R&D Ethics & Compliance Takeda Pharmaceuticals Assoc Dir GHH Compliance Merck & Co Remediation Specialist Novo Nordisk Health Care Compliance Officer Dir Corp Compliance Auxilium Pharmaceuticals CCO North America Galderma Laboratories VP Healthcare Compliance Dir Compliance INSYS Therapeutics Medical Science Liaison Sigma Tau Pharmaceuticals Dir Huron Life Sciences Engagement Exec LRN Mgr Potomac River s Chief Compliance & SVP Sunovion Pharmaceuticals
18 SVP & CCO Salix Pharmaceuticals Assist General Counsel Pfizer CEO & President MediSpend Sr Mgr Compliance LEO Pharma Principal CCO VP Strategic Consulting Compliance Implementation Services (CIS) Chief Ethics Compliance Officer Eisai Healthcare Compliance Officer Mgr Regulatory & Compliance Services Porzio Life Sciences LLC Sr Compliance Counsel Privacy Officer Otsuka America Ethics & Compliance Officer Actavis Sr Mgr VP CCO Merz Pharmaceuticals Sr Mgr Mgr Compliance Auditing Otsuka Assoc Dir Legal LEO Pharma Attorney Axiom
19 Sr Counsel Bristol-Myers Squibb Medicaid Rebate Analyst Genzyme a Sanofi Company VP & CCO Ethics Compliance Novartis Pharmaceuticals Corporation Sr Analyst Dir Healthcare Compliance Cert Program Seton Hall Law School Assoc Dir Navigant Compliance Ops Mgr inventiv Health Assoc Dir Compliance Sandoz Managing Principal Porzio Bromberg & Newman Sr Compliance Mgr Dyax Corp Dir Compliance Monitoring & Investigation Shire Pharmaceuticals Compliance & Risk Management Advisory Services Berkeley Research Group LLC Dir Reg Ad & Promotion Sr Mgr Mgr State & Federal Disclosure Takeda Pharmaceuticals Dir Education & Life Sciences Huron Consulting Group Sr Mgr Principal Porzio Bromberg & Newman PC
20 Assist General Counsel Pfizer Ethics & Compliance Officer Business Compliance AbbVie VP Legal Affairs Dep Gen Counsel & CCO AMAG Pharmaceuticals Chief Compliance Officer Novo Nordisk Dir Navigant Lead Analyst Health Care Compliance Sr Dir Compliance Daiichi Sankyo Compliance Officer Eli Lilly Sr Dir HCC Governance Metrics & Reporting VP Compliance Officer & Assoc General Horizon Pharma Managing Dir BRG Mgr IT Global Finance Assoc Dir Sr Corp Counsel BioPharm Legal Sandoz Dir Compliance Teva Pharmaceuticals Assoc General Counsel Merz North America Dir Health Care Compliance Officer VP Global Compliance Officer PAREXEL Dir Account Management AstraZeneca
21 VP Porzio Life Sciences LLC Dir Bus Dev Compliance Implementation Services CIS Dir Global Compliance & Security Mylan Dir Sales Ops MedPro Systems Sr Mgr Director of Compliance The Medicines Company Mgr Health Care Compliance Sr Dir NA Compliance Team Sanofi US Dir OPDP FDA Exec Dir Global R&D Compliance & Audit Amgen VP CCO Otsuka Pharmaceutical
6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality
6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality March 24-25, 2015 Wyndham Philadelphia Historic District, Philadelphia, PA www.exlevents.com/gcp Sponsors
PARTIAL DELEGATE LIST (as of Jan. 15, 2013) Electronic Data in Clinical Trials /Integration and Leveraging Clinical Trial Operations Data Conferences
PARTIAL DELEGATE LIST (as of Jan. 15, 2013) Electronic Data in Clinical Trials /Integration and Leveraging Clinical Trial Operations Data Conferences February 5-7, 2013 - Hyatt Regency Miami Miami, FL
Outcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct
Outcomes of Monitoring Committee Reviews Medicines Australia Code of Conduct 1 Medicines Australia ABN 23 126 990 001 Level 1, 16 Napier Close Deakin ACT 2600 Phone: 02 6122 8500 Fax: 02 6122 8555 Web:
CHEM-E4140 Selectivity 12. Pharma Business
CHEM-E4140 Selectivity 12. Pharma Business Prof. Ari Koskinen Laboratory of Organic Chemistry C318 Pharma Business Total volume ca 1100 G$ (Shell 421G$; Walmart 486G$; Toyota 252 G$). Annually approx 25
Rx-360 An International Pharmaceutical Supply Chain Consortium
Rx-360 An International Pharmaceutical Supply Chain Consortium Overview Rx-360 and the Audit Sharing Program September 2011 Rx-360 Members (Continuously updated list at www.rx-360.org) Manufacturers (24)
ehealthinsight Series: Online Patient Recruitment Strategies
A Datamonitor report ehealthinsight Series: Online Patient Recruitment Strategies Published: May-08 Product Code: Providing you with: Overview of benefits and drawbacks of online Analysis of online patient
PPRS 2014 analysis of growth in spend of branded medicines. DH Leading the nation s health and care
PPRS 2014 analysis of growth in spend of branded medicines March 2015 Executive Summary IMS Health data shows growth in spend in 2014 (compared to 2013) of 8.2% on branded medicines. This is higher than
Clinical trial research agreement Agreed schedule 4 or 7 clause amendments
Clinical trial research agreement Agreed schedule 4 or 7 clause amendments Medicines Australia and Medical Technology Association of Australia templates The sponsors in the table have agreed clauses for
KEEPING CLINICAL TRIALS IN AUSTRALIA
OCCASIONAL PAPER SERIES KEEPING CLINICAL TRIALS IN AUSTRALIA WHY ACTION IS NEEDED NOW OCCASIONAL PAPER SERIES > Medicines Australia is producing Occasional Papers to promote a contest of ideas, thought
December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES
December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES by Dennis van Rooij with Tim van Tongeren EXECUTIVE SUMMARY More than half of pharma marketers don t or can t leverage
e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015
e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015 PHARMAPACK 2015 1 Mobile health x2 30 months 100 000 mapps Source: research2guidance, mhealth App Market Report 2013-2017
VAB REPORT: ITS TIME FOR A CHECK UP! UPDATE ON THE HEALTHCARE INDUSTRY
VAB REPORT: ITS TIME FOR A CHECK UP! UPDATE ON THE HEALTHCARE INDUSTRY SUMMARY Healthcare Summary Personal health care expenditures projected to grow 26% in the next 4 years Hospital care sector comprises
The 2015 Avoca Report. Clinical Development Innovation. Sponsor and Provider Views on Innovation in Outsourced Clinical Development
The 2015 Avoca Report Clinical Development Innovation Sponsor and Provider Views on Innovation in Outsourced Clinical Development Contents Section Slides Research Overview 3-5 Respondent Demographics 6-9
Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus)
A Datamonitor report Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus) Published: Oct 07 Product Code: DMTC2133 Providing you with: Identifies which technology vendors
Stakeholder Perspectives: Mild Cognitive Impairment and Dementia
A Datamonitor In-Depth Analysis Stakeholder Perspectives: Mild Cognitive Impairment and Dementia Aricept in Race to Pioneer Unexplored Markets Published: Aug-03 Product Code: DMHC1924 Why buy this analysis?
Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019
Brochure More information from http://www.researchandmarkets.com/reports/3453273/ Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Description: About non-small cell lung cancer therapeutics
Pharmaceutical Marketing Disclosures
Pharmaceutical Marketing Disclosures July 1, 2007 June 30, 2008 Report of Vermont Attorney General William H. Sorrell April 2009 Prepared by staff of the Vermont Attorney General s Office: Wendy Morgan,
OFFICE OF ATTORNEY GENERAL LAWRENCE G. WASDEN AVERAGE WHOLESALE PRICE LITIGATION REPORT AUGUST 2013
Introduction OFFICE OF ATTORNEY GENERAL LAWRENCE G. WASDEN AVERAGE WHOLESALE PRICE LITIGATION REPORT AUGUST 2013 In 2007, Attorney General Wasden filed lawsuits against 33 pharmaceutical companies for
Annual Press Conference 2012. Business Year 2011
Business Year 2011 Highlights of the Business Year 2011 Andreas Barner Chairman of the Board of Managing Directors Corporate Board Division Pharma Research, Development and Medicine Value through Innovation
2013 Conference Attendees. Social Media Subject Matter Expert
2013 Conference Attendees Company Actiance Actiance, Inc. Actiance, Inc. Alabama Department of Insurance Insurance Company of North America Services Allstate Life Insurance Company American Amicable Life
Commercial Insight Osteoarthritis and Rheumatoid Arthritis
A Datamonitor In-Depth Analysis Commercial Insight Osteoarthritis and Rheumatoid Arthritis New Growth In A Mature Market Published: Jul-03 Product Code: DMHC1891 Why buy this analysis? Target current and
M&A und Allianzen in Life Science Aktuelle Entwicklungen und Trends
M&A und Allianzen in Life Science Aktuelle Entwicklungen und Trends Symposium Life Science am Kapitalmarkt Frankfurt, 3. Juni 28 Global biotech industry Strong growth in most areas but Visible product
Pharma working capital performance highly variable
April 2014 Pharma working capital performance highly variable 41 Billion in Excess Working Capital We last completed this survey in 2012. We expected that there would be a broad improvement across the
Global Peptide Therapeutics Market 2014-2018
Brochure More information from http://www.researchandmarkets.com/reports/3022209/ Global Peptide Therapeutics Market 2014-2018 Description: About Peptide Therapeutics Peptides are amino acids sequences
INCENTIVE COMPENSATION CONFERENCE
Announcing the 2nd Annual ZS Associates INCENTIVE COMPENSATION CONFERENCE 08 September 23 24, 2008 Philadelphia, PA Incentive compensation greatly affects sales force motivation and morale. When designed
Black Mountain Consulting Group. Not just Knowledge..Know-How
Black Mountain Consulting Group Not just Knowledge..Know-How BMCG in a Nutshell. A collaborative of more than 45 Pharmaceutical Industry experts, each with more than 10 years of success in their well defined
Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries
Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries April 16, 2010 Oracle is currently reviewing the existing Phase Forward product roadmap and will be
Health Reform s New Frontier: Balancing Cost, Value and Innovation
Health Reform s New Frontier: Balancing Cost, Value and Innovation A panel discussion Genzyme Corporation Cambridge, MA February 23, 2010 Welcome from NEHI s President NEHI Members and Friends: In this
Rx-360Upstream Supply Chain Security A Supplier Collaborative Approach to Mitigate Risk and Enhance Transparency
Rx-360Upstream Supply Chain Security A Supplier Collaborative Approach to Mitigate Risk and Enhance Transparency www.rx-360.org www.rx-360.org Presenter: Rob Welsh, VWR International, LLC VP Category Management
Regulatory Compliance Officer - Advertising Principal. National VP, Sales Development Director, Corporate Digital Communications
Company Name Adrea Rubin Marketing Inc. Adrea Rubin Marketing Inc. Advisology AIG/The Variable Annuity Life Insurance Co Allianz Life Insurance Company of NA Allstate Financial American National Family
Digital Leaders Deal With a Range of Organizational Challenges
May 22, 2014 OVERCOMING OBSTACLES TO DIGITAL TRANSFORMATION SUCCESS IN THE PHARMACEUTICAL INDUSTRY Digital Leaders Deal With a Range of Organizational Challenges by Tim van Tongeren with Dennis van Rooij
Main Conference Agenda
Sponsored by: (Co-located with Bioequivalence: Intersection between Science & Regulatory Conference) Main Conference Agenda Day One Wednesday, November 5 th, 2014 7:30 Registration Opens & Continental
In the largest and perhaps the most ambitious collaborative
FEATURES THE BIRTH OF TRANSCELERATE BIOPHARMA, INC. Revolution in Clinical Research Partnerships by Dalvir Gill and Garry Neil In the largest and perhaps the most ambitious collaborative effort ever initiated
CODE FOR DISCLOSURE OF TRANSFERS OF VALUE BY PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTH ORGANIZATIONS
CODE FOR DISCLOSURE OF TRANSFERS OF VALUE BY PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTH ORGANIZATIONS Adopted November 2013, in force since 1 st of January 2014. INTRODUCTION The Association
Avoca s Quality Metrics Consulting Service Offering
Avoca s Quality Metrics Consulting Service Offering Avoca s Quality Metrics Consulting The Challenge Biopharmaceutical companies and CROs struggle in defining how best to utilize quality metrics to optimize
Senior Vice-President, Enrollment Technology Solutions. VP Corporate Development Vice President, Product Development and Marketing Strategy
Preferred Company Name Title Description 5 Star Life Insurance Company Sr. Vice President Business Insurance Markets 5 Star Life Insurance Company Operations Manager A.M. Best Co. FSenior Financial Analyst
Case 1:15-cv-01120-UNA Document 1 Filed 12/03/15 Page 1 of 49 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:15-cv-01120-UNA Document 1 Filed 12/03/15 Page 1 of 49 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE UNIMED PHARMACEUTICALS, LLC, BESINS HEALTHCARE INC., and BESINS
Current Attendees Discovery On Target 2012
Current Attendees Discovery On Target 2012 Director Dev Projects, Development, 4SC AG Assoc Research Fellow, Neuroscience & Pain, Abbott Labs Assoc Director, Abbott Labs CEO, ACADIA Pharmaceuticals Inc
Brochure More information from http://www.researchandmarkets.com/reports/3292678/
Brochure More information from http://www.researchandmarkets.com/reports/3292678/ Asia Pacific (India, China, Australia, South Korea & Others) Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long
Great Expectations: Enhanced Obligations in Recent HHS-OIG Corporate Integrity Agreements
Thomas W. Beimers Special Counsel Faegre Baker Daniels LLP Minneapolis MN Great Expectations: Enhanced Obligations in Recent HHS-OIG Corporate Integrity Agreements The Department of Health & Human Services,
PROGRAM PLAN FOR THE ONTARIO MEDICATIONS RETURN PROGRAM
PROGRAM PLAN FOR THE ONTARIO MEDICATIONS RETURN PROGRAM April 2013 Executive Summary Ontario Regulation 298/12 "Collection of Pharmaceuticals and Sharps - Responsibility of Producers" came into force on
Sharing Industry Clinical Trial Data: Improving Public Health While Maintaining the Oversight Relationship Between Regulator and Sponsor
Sharing Industry Clinical Trial Data: Improving Public Health While Maintaining the Oversight Relationship Between Regulator and Sponsor Steven Snapinn SCT/QSPI/FDA Workshop Innovations in the Science
Research to Real-World Application: Experts Weigh In on the Underuse of Anticoagulants
Publishing Staff Senior Vice President of Operations and Clinical Affairs Jeff D. Prescott, PharmD, RPh Senior Clinical Projects Manager Ida Delmendo Clinical Projects Manager Tara Petersen Project Director
EU Clinical Trials Register
EU Clinical Trials Register Sponsor Contact Information Abbott Laboratories Ltd Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire SL6 4XE UK Telephone number +44 1628 644475 euclinicaltrials@abbott.com
PHARMACEUTICAL INDUSTRY PROFILE
PHARMACEUTICAL INDUSTRY PROFILE I. INDUSTRY BACKGROUND A. Industry Definition The U.S. pharmaceutical industry is defined by the Census Bureau as companies engaged in researching, developing, manufacturing,
Stakeholder Insight: Insulin Use in Type 2 Diabetes
A Datamonitor Report Stakeholder Insight: Insulin Use in Type 2 Diabetes From Last Resort to Early Intervention Published: May-04 Product Code: DMHC1989 Providing you with: Analysis of Datamonitor s Diabetes
NCPA 2006 Exhibitors (as of 9/25/06) American Pharmacists Association www.aphanet.org Booth 907. /alert Marketing www.alertmarketing.
NCPA 2006 Exhibitors (as of 9/25/06) /alert Marketing www.alertmarketing.com Booth 530 21st Century Healthcare www.21stcenturyvitamins.com Booth 147 A & D Medical Lifesource www.lifesourceonline.com Booth
Commercial Perspectives: Multiple Sclerosis
A Datamonitor Report Commercial Perspectives: Multiple Sclerosis How to Find Opportunities in an Unremitting Market Published: Jun-04 Product Code: Providing you with: In-depth profiles of current market-leading
Blockbuster!!! Content Management in the Pharmaceutical Industry An Overview. Global Pharma Market Shares by Sales (Approx. USD 700 Billion) Global
Content Management in the Pharmaceutical Industry An Overview Blockbuster!!! Avatar USD 2 Billion revenues Lipitor USD 12.5 Billion in 2008 Dr Arun Gangatkar http://in.linkedin.com/in/drarungangatkar drarunj@gmail.com
Attendee Titles and Companies
Attendee Titles and Companies Job Title Market Segment Liaison - Health Insurance Corporate Actuary Executive Director Director, Insurance Claims Senior Actuarial Analyst Sr. Actuarial Associate Sr. VP,
2014 & 13 th Annual China Pharmaceutical, Life Science & Healthcare Industry Summit
2014 & 13 th Annual China Pharmaceutical, Life Science & Healthcare Industry Summit Addressing the most critical issues facing China s pharma & life science sector 10 th & 11 th April, 2014 Shanghai China
COMPLIANCE Solutions. Risky Business? Haunting Prose. 2012 In The Line Of Fire. Responsible Executive MEDICAL DEVICE BUTLER SNOW.
MEDICAL DEVICE COMPLIANCE Solutions Spring, 2012 BUTLER SNOW Haunting Prose Ghostwriting and Transparency in Pharmaceutical and Medical Device Publications Risky Business? Assessing Risks with A Risk Assessment
INTERNATIONAL PHARMACEUTICAL PRIVACY CONSORTIUM COMMENTS IN RESPONSE TO THE CALL FOR EVIDENCE ON EU DATA PROTECTION PROPOSALS
INTERNATIONAL PHARMACEUTICAL PRIVACY CONSORTIUM COMMENTS IN RESPONSE TO THE CALL FOR EVIDENCE ON EU DATA PROTECTION PROPOSALS I. INTRODUCTION The International Pharmaceutical Privacy Consortium (IPPC)
AHIC Transition Update
AHIC Transition Update September 25, 2008 Mary Jo Deering, Ph.D. Lead for AHIC Transition Activities Office of the National Coordinator 1 Initiating the Transition January, 2008, Secretary Michael O. Leavitt
The University of Toledo Main Campus Salary Schedule Effective 07/01/2010
Academic Advisor Ex Student & Academic Support $ 32,000 $ 40,000 $ 48,000 4 Academic Affairs Spec Ex Administrative Services $ 32,000 $ 40,000 $ 48,000 4 Academic Prog Coor Ex Student & Academic Support
Serialization Technology - Seidenader: Integral Solution Provider
Serialization Technology - Seidenader: Integral Solution Provider Sindusfarma August, 28th 2013 Dr. Stefan Loelkes Agenda 1 2 Your challenge Company overview 3 4 Integral solution provider Products 2 Your
Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015
Brochure More information from http://www.researchandmarkets.com/reports/3398017/ Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015 Description: Small-Cell Lung Cancer Global Clinical Trials
Global Pharmaceuticals Marketing Channel Reference EDITION
Global Pharmaceuticals Marketing Channel Reference EDITION 2015 ABOUT IMS HEALTH IMS Health is a leading global information and technology services company providing clients in the healthcare industry
Pharma working capital leaves room for improvement
October 2012 Pharma working capital leaves room for improvement 50.7 Billion in Excess Working Capital Ten years ago it was not unusual to be asked why working capital mattered to a pharmaceutical company.
THE GABOR DANIELFY SCHOLARSHIP FOR HEALTHCARE COMPLIANCE & ETHICS
THE GABOR DANIELFY SCHOLARSHIP FOR HEALTHCARE COMPLIANCE & ETHICS I. Mission: Seton Hall Law School, Sciences Po, and ETHICS - the International Society of Healthcare Ethics and Compliance Professionals,
4 th Annual Clinical Development and Trials Asia Congress. 5 th Annual Pharma R&D World Asia Congress
Oxford Global Medical Conferences Imaging technologies are proud to present the 4 th Annual Clinical Development and Trials Asia Congress and Implementing biomarkers in co-located early phase Pharma clinical
PANAGORA PHARMA CUSTOMER EXPERIENCE SUMMIT 14
PANAGORA PHARMA CUSTOMER EXPERIENCE SUMMIT 14 March 5-6, 2014 Princeton, NJ The Nassau Inn Identify, Prioritize and Solve Key Operational Challenges that Shape the Customer Experience in Pharma GOLD SPONSORS
American Health Lawyers Association
American Health Lawyers Association Manchester Grand Hyatt 2013 American Health Lawyers Association This publication is designed to provide accurate and authoritative information in regard to the subject
The power of creativity www.originbranding.com. Pharmaceutical Branding 2012
The power of creativity www.originbranding.com Pharmaceutical Branding 2012 We are an independent, boutique agency passionately focused on developing pharmaceutical brands. For over 15 years we have delivered
To know more about Pharmacovigilance and Clinical Trials Data Management
To know more about Pharmacovigilance and Clinical Trials Data Management 1. What is Pharmacovigilance? Pharmacovigilance (PV) is the pharmacological science related to the detection, assessment, understanding
The University of Georgia Positions of Trust (Classification Level)
The omission of any title on this list does not preclude it from becoming a Position of Trust in the future. This list will be revised as appropriate in the best interest of the university. In addition,
Pipeline Insight: Schizophrenia Asenapine; A future market leader?
A Datamonitor report Pipeline Insight: Schizophrenia Asenapine; A future market leader? Published: Jul-06 Product Code: DMHC2186 Providing you with: Detailed pipeline analysis for key products in development
Delegate List (as of 7.31)
Delegate List (as of 7.31) Company Title Department 3M Co Mgr Bus Dev Accentia Biopharmaceuticals Aeneas Medical Consulting LLC Principal AFFiRiS AG Proj Mgr Aldevron Mgr Client Relations Aldevron President
1) SCOPE OF THE PROGRAM
CALL FOR PROJECTS 2015/16 CANADA/GERMANY JOINT PROGRAM DEADLINE: 15 TH JANUARY 2016 1) SCOPE OF THE PROGRAM The main goal of the Canada/Germany joint program is to strengthen research in Canada and Germany
Stakeholder Insight: Multiple Sclerosis Disease-modifying Efficacy and Side Effects Guide Treatment Choice
A Datamonitor report Stakeholder Insight: Multiple Sclerosis Disease-modifying Efficacy and Side Effects Guide Treatment Choice Published: Dec-06 Product Code: Providing you with: An overview of epidemiology,
CME/CNE Evaluation & Certification Instructions
CME/CNE Evaluation & Certification Instructions The American College of Cardiology Foundation (ACCF) will e-mail an online evaluation to each participant in this CME/CNE activity. The online evaluation
Funderingar om etik i medicinsk forskning. Hálfdán Pétursson PhD Forskare och ST-läkare
Funderingar om etik i medicinsk forskning Hálfdán Pétursson PhD Forskare och ST-läkare Etik i medicinsk forskning I. Ärlighet II. Mänskliga rättigheter och grundläggande medicinsk etik III. Metodik IV.Den
Campbell Alliance. Press Kit Materials
Campbell Alliance Press Kit Materials Raleigh, N.C. Parsippany, N.J. Woodland Hills, Calif. South San Francisco Chicago New York City TABLE OF CONTENTS Document Page # About Campbell Alliance 3 Company
ATTACHMENT B ENHANCED COMPLIANCE MEASURES AND CERTIFICATIONS. After the conduct described in the Information had ceased and prior to entering
ATTACHMENT B ENHANCED COMPLIANCE MEASURES AND CERTIFICATIONS After the conduct described in the Information had ceased and prior to entering into the Deferred Prosecution Agreement (the Agreement ), Genzyme
The Digest of Biotech Job Trends Massachusetts BRIEF II: ENTRY LEVEL JOBS REQUIRING AN ASSOCIATE DEGREE OR BELOW
The Digest of Biotech Job Trends Massachusetts 2015 BRIEF II: ENTRY LEVEL JOBS REQUIRING AN ASSOCIATE DEGREE OR BELOW About the Digest 2 The Digest of Biotech Jobs Trends in Massachusetts consists of an
Accelerating Drug & Clinical Trial Approvals in China & East Asia
25 28 March 2014 The Westin Beijing Chaoyang, Accelerating Drug & Clinical Trial Approvals in & East Asia What s New in 2014? Key Regulatory Update from the National Institute for Food & Drug Control,
KENTUCKY STATE UNIVERSITY ORGANIZATION
ORGANIZATION BOARD OF REGENTS PRESIDENT Special Asst. for Strategic Plan. & Dev. School District Outreach Special Projects Thorobred Center Chief of Operations Institutional Special Asst. for Security
R&D Compliance: Prepare Now for Future Enforcement
R&D Compliance: Prepare Now for Future Enforcement Dennis K. Barnes, JD, MBA, CPA VP, Chief Compliance Officer Parexel International Paul Curtin, JD, CFE Exec. Director, R&D Compliance Allergan George
Review of U.S. Coast Guard's FY 2014 Drug Control Performance Summary Report
Review of U.S. Coast Guard's FY 2014 Drug Control Performance Summary Report January 26, 2015 OIG-15-27 HIGHLIGHTS Review of U.S. Coast Guard s FY 2014 Drug Control Performance Summary Report January 26,
Osteoporosis Drug Development Moving Forward Public Workshop
Osteoporosis Drug Development Moving Forward Public Workshop November 4, 2015 Discussion Panel Members and Speakers Robert Adler, MD Chief, Endocrinology and Metabolism McGuire Veterans Affairs Medical
2015 LOMA Customer Service Conference Attendees
2015 Customer Service Conference Attendees Job Title Business Specialist Sales and Client Management Sales Technical Officer, Life Policyowner Service Vice President, Enterprise Operations Operations Relationship
The United States False Claims Act Qui Tam Whistleblower Law
The United States False Claims Act Qui Tam Whistleblower Law Getnick & Getnick LLP Counsellors At Law Rockefeller Center, 620 Fifth Avenue New York, NY 10020 Phone: (212) 376-5666 Fax: (212) 292 3942 www.getnicklaw.com
Complying with the FCPA - An Exploration of Ethical Issues Raised by Recent Cases: Lessons Learned from Recent Enforcement Actions
Complying with the FCPA - An Exploration of Ethical Issues Raised by Recent Cases: Lessons Learned from Recent Enforcement Actions Philip S. Brewster Brewster Law Firm LLC July 29, 2014 Schering Charitable
When the mission is hiring top talent, look to Sawyer TMS for answers.
Your Trusted Search Partner When the mission is hiring top talent, look to Sawyer TMS for answers. Engage Sawyer TMS and your organization benefits from our intense focus, our time proven, highly specialized
BRIDGEPORT HOSPITAL ANNUAL REPORTING FISCAL YEAR 2013 REPORT 19 - SALARIES AND FRINGE BENEFITS OF THE TEN HIGHEST PAID HOSPITAL POSITIONS
BRIDGEPORT HOSPITAL 1. President & CEO $911,931 $310,091 $1,222,022 2. Exec. VP/Administration $697,172 $232,733 $929,905 3. Senior VP of Finance & CFO $590,950 $205,127 $796,077 4. Sr. VP/Medical Affairs
Sequential Parallel Comparison Design (SPCD) in CNS Clinical Trials
Sequential Parallel Comparison Design (SPCD) in CNS Clinical Trials Maurizio Fava, MD Executive Vice Chair, Department of Psychiatry Director, Depression Clinical and Research Program Massachusetts General
CONTRACT RESEARCH ORGANIZATION INDUSTRY OVERVIEW
CONTRACT RESEARCH ORGANIZATION INDUSTRY OVERVIEW April 2014 Investment banking services are provided by Harris Williams LLC, a registered broker-dealer and member of FINRA and SIPC, and Harris Williams
Public Policy & Market Influence
B Public Policy & Market Influence Pharmaceutical companies operate in an environment where low R&D success rates a, the pressure to maintain profits and a fiercely competitive landscape can increase the
Guide. Astellas Pharma US, Inc. XTANDI Access Services SM 2015 NCCN Virtual Reimbursement Resource Room. NCCN.org/reimbursement
Astellas Pharma US, Inc. XTANDI Access Services SM 2015 NCCN Virtual Reimbursement Resource Room Guide The oncology reimbursement landscape continues to present ever-evolving challenges for clinicians
June 28-29 Washington, DC SPONSORSHIP OPPORTUNITIES
June 28-29 Washington, DC SPONSORSHIP OPPORTUNITIES OVERVIEW Due rising out-of-pocket consumer healthcare costs, the recently passed healthcare reform legislation, and new technology innovation, the healthcare
Secure Digital Identities for Authentication & Signing in an Electronic Healthcare Community
Secure Digital Identities for Authentication & Signing in an Electronic Healthcare Community John Hendrix; Program Director CTST 2009 Overview Challenges to Secure Transactions in an Electronic Environment
Social Media and Compliance Specialist Regional Manager, Social Media
Company Name Title Description 451 Marketing EVP - Financial Services ACE Group (Combined) AVP, Interactive Communications Actiance Social Media and Compliance Specialist Actiance Regional Manager, Social
Patterns and predictors of suicides in the U.S. Army: An introduction to the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS)
Patterns and predictors of suicides in the U.S. Army: An introduction to the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS) Ronald C. Kessler, Ph.D. Harvard Medical School March
Biopharmaceutical Raw Materials throughout the Product Lifecycle
February 27 March 2, 2012 Hilton San Diego Bayfront San Diego, CA Monday Tuesday Programming: IBC s 17th International Process & Analytical Assay Validation IBC s 8th International Outsourcing Manufacturing
How To Understand And Understand Biosimilars
Welcome to Biosimilars 20/20, presented by the Specialty Pharma Education Center (SPEC) in partnership with the Specialty Pharma Journal (SPJ). Please note that this is a preliminary agenda that is subject
EvaluatePharma World Preview 2015, Outlook to 2020
EvaluatePharma World Preview 2015, Outlook to 2020 8th Edition June 2015 Welcome to the EvaluatePharma World Preview 2015, Outlook to 2020 The eighth edition of EvaluatePharma s World Preview brings together
MARION COUNTY FY 2011-12 BUDGET APPENDIX I POSITIONS BY DEPARTMENT, TITLE AND SALARY RANGE
Department: Assessor's Office Appraisal Section Supervisor 3.00 $47,590 $74,402 Assessment Clerk 13.00 $28,829 $44,262 Assessment Clerk Sr 5.00 $31,470 $48,256 Assessor 0.10 $85,925 $92,518 Assessor's
Loss Control Webinar Series. The Year That Was: 2014 (And On the Horizon in 2015)
Loss Control Webinar Series The Year That Was: 2014 (And On the Horizon in 2015) Sonia M. Valdes, Esq. Vice President-Medmarc Carolyn Taylor, Esq. Partner, Morris Polich and Purdy 1 Presentation Topics
Life Sciences Outlook. New Jersey 2015
Life Sciences Outlook New Jersey 2015 New Jersey M&A activity in New Jersey has led to the consolidation of surplus real estate holdings and diminished head counts. However, midsized companies are helping
Jobbetegnelser for det nuværende job i branchen
Jobbetegnelser for det nuværende job i branchen Administrerende direktør (CEO) Academic, Project manage Advanced Business Analyst Advanced Business Analyst, IT&CD, IT System Management Analytical Service